Enlivex Announces the Dosing of the First Patient in a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis
Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal ...
gadgets36020h
Infinix Tablets
The firm claims to have local subsidiaries in over 60 countries. Infinix's latest mobile launch is the XPad. The tablet was launched in 13th September 2024. The tablet comes with a 11.00-inch ...